# FDA Inspection 1167681 - Kappa Laboratories, Inc. - April 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/kappa-laboratories-inc/274e2edb-065e-41c1-bfb4-3744dbfe2906
Source feed: FDA_Inspections

> FDA Inspection 1167681 for Kappa Laboratories, Inc. on April 22, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167681
- Company Name: Kappa Laboratories, Inc.
- Inspection Date: 2022-04-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271683 - 2025-06-04](https://www.keypedia.com/records/fda_inspections/kappa-laboratories-inc/9853688b-01f8-440c-b06c-898d27ae2c6f)
- [FDA Inspection 1029683 - 2017-08-25](https://www.keypedia.com/records/fda_inspections/kappa-laboratories-inc/0dda8eea-51ac-4e5d-b4f0-e7b987302458)

Company: https://www.keypedia.com/companies/kappa-laboratories-inc/f57ed33f-b9d5-485c-a477-8fd51684e2ee

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c